We are live on ! Find out more
VTYX

Ventyx Biosciences
VTYX

Delisted

VTYX was delisted on the 3rd of March, 2026.

Back to rankings

117 hedge funds and large institutions have $132M invested in Ventyx Biosciences in 2024 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 37 increasing their positions, 37 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 37

7% less funds holding

Funds holding: 126 → 117 (-9)

18.37% less ownership

Funds ownership: 99.58% → 81.21% (-18%)

25% less call options, than puts

Call options by funds: $670K | Put options by funds: $896K

28% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 29

59% less capital invested

Capital invested by funds: $324M → $132M (-$192M)

Holders
117
Holders Change
-9
Holders Change %
-7.14%
% of All Funds
1.69%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
21
Increased
37
Reduced
37
Closed
29
Calls
$670K
Puts
$896K
Net Calls
-$226K
Net Calls Change
-$431K

Top Buyers

Rank Fund Capital Flow
1
Capital International Investors
Capital International Investors
California
+$12M
2
DM
Deerfield Management
New York
+$9.5M
3
VPC
Vestal Point Capital
New York
+$5.46M
4
BlackRock
BlackRock
New York
+$4.26M
5
OCA
Octagon Capital Advisors
New York
+$3.7M

Top Sellers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
-$14.9M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$13.9M
3
O
OrbiMed
New York
-$10.3M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$6.96M
5
SSA
Schonfeld Strategic Advisors
New York
-$5.04M
Name Holding Trade Value Shares
Change 		Change in
Stake
Macquarie Group
26
Macquarie Group
Australia
$993K – – –
Connor, Clark & Lunn Investment Management (CC&L)
27
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$969K -$233K -56,049 -12%
Bank of America
28
Bank of America
North Carolina
$954K +$457K +109,894 +36%
QUSVM
29
Qiming U.S. Ventures Management
Washington
$952K – – –
Millennium Management
30
Millennium Management
New York
$922K -$305K -73,364 -16%
Northern Trust
31
Northern Trust
Illinois
$910K -$12.5K -3,017 -0.8%
WP
32
Woodline Partners
California
$876K +$1.58M +379,175 New
TCM
33
TCG Crossover Management
California
$730K -$2.08M -499,529 -61%
BC
34
BIT Capital
Germany
$704K +$515K +124,052 +69%
Acadian Asset Management
35
Acadian Asset Management
Massachusetts
$608K +$1.1M +263,565 New
Two Sigma Investments
36
Two Sigma Investments
New York
$547K +$620K +149,174 +170%
Bank of New York Mellon
37
Bank of New York Mellon
New York
$533K +$353K +84,984 +58%
GCM
38
Graham Capital Management
Connecticut
$510K +$918K +220,929 New
Two Sigma Advisers
39
Two Sigma Advisers
New York
$492K +$518K +124,600 +141%
CSS
40
Cubist Systematic Strategies
Connecticut
$345K +$387K +93,247 +166%
Invesco
41
Invesco
Georgia
$340K +$8.4K +2,021 +1%
Jane Street
42
Jane Street
New York
$337K +$100K +24,178 +20%
N
43
Nuveen
North Carolina
$310K – – –
Fidelity Investments
44
Fidelity Investments
Massachusetts
$293K -$1.05M -251,589 -66%
BFM
45
Boothbay Fund Management
New York
$292K -$77.1K -18,566 -13%
JF
46
Jump Financial
Illinois
$244K +$440K +105,836 New
AllianceBernstein
47
AllianceBernstein
Tennessee
$234K +$213K +51,300 +103%
HighTower Advisors
48
HighTower Advisors
Illinois
$230K +$7.98K +1,921 +2%
Mariner
49
Mariner
Kansas
$221K -$85.6K -20,608 -18%
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$209K +$103K +24,885 +38%
1
2
3 4 5

VTYX Hedge Fund Activity: Q2 2024 in Review

117 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Ventyx Biosciences (VTYX) for Q2 2024, worth a combined $132M — down 59% from $324M a quarter earlier.

Sellers outnumbered buyers: 29 funds closed out of VTYX and 21 opened new positions — a net loss of 8 holders — while 37 trimmed existing stakes and 37 added.

The largest buyer was Capital International Investors, adding an estimated $12M. The largest seller was Cormorant Asset Management, exiting entirely with an estimated $14.9M sold.

  • 117 institutional investors held Ventyx Biosciences (VTYX) as of Q2 2024, down from 126 in Q1 2024.
  • Funds reported $132M of Ventyx Biosciences stock for Q2 2024, down 59% quarter-over-quarter.
  • 21 funds opened new Ventyx Biosciences positions in Q2 2024 and 29 closed out, a net change of -8 holders.
  • The largest Ventyx Biosciences buyer in Q2 2024 was Capital International Investors, an estimated $12M added.
  • The largest Ventyx Biosciences seller in Q2 2024 was Cormorant Asset Management, an estimated $14.9M sold.

Based on aggregated 13F filings for Q2 2024.